Table II.
Variable | EC (N = 7) | CLE (N = 11) | P value |
---|---|---|---|
Epidermis, n (%) | |||
Lymphocyte exocytosis | 3 (43) | 7 (64) | .63 |
Confluent necrosis | 1 (14) | 0 (0) | .39 |
Apoptotic keratinocytes | 2 (29) | 4 (36) | >.99 |
Vacuolized basement membrane zone | 1 (14) | 8 (73) | .049 |
Papillary dermis | |||
Edema, n (%) | 4 (57) | 2 (18) | .14 |
Lymphocyte infiltrate intensity score,∗ median (range) | 2 (1-3) | 2 (1-3) | .34 |
Lymphocyte infiltrate localization, n (%) | |||
Perivascular localization | 7 (100) | 11 (100) | >.99 |
Interstitial localization | 3 (43) | 8 (73) | .33 |
Other inflammatory cell infiltrate, n (%) | 2 (29) | 3 (27) | >.99 |
Lymphocytic vasculitis, n (%) | 5 (71) | 1 (9) | .01 |
Congestive vessels, n (%) | 2 (29) | 0 (0) | .13 |
Red blood cell extravasation, n (%) | 4 (57) | 1 (9) | .047 |
Reticular and deep dermis | |||
Lymphocyte infiltrate intensity score,∗ median (range) | 2 (1-3) | 2 (0-3) | .77 |
Lymphocyte infiltrate localization, n (%) | |||
Perivascular | 7 (100) | 10 (91) | >.99 |
Interstitial | 0 (0) | 0 (0) | >.99 |
Perieccrine | 6 (86) | 7/10 (70)† | .60 |
Perineural | 4 (57) | 7/9 (78)‡ | .59 |
Other inflammatory cell infiltrate, n (%) | 2 (29) | 3 (27) | >.99 |
Lymphocytic vasculitis, n (%) | 4 (57) | 7 (64) | >.99 |
Leukocytoclastic vasculitis, n (%) | 1 (14) | 1 (9) | >.99 |
Congestive vessels, n (%) | 3 (43) | 1 (9) | .24 |
Neural section, median (range) | 5 (2-9) | 3 (0-4) | .008 |
Hypodermis§ | |||
Perivascular lymphocyte infiltrate, n (%) | 2/2 (100) | 0/2 (0) | .33 |
Immunohistochemical features | |||
Case with MxA+ cells, n (%) | 7 (100) | 10/10 (100)‖ | >.99 |
MxA expression, median (range) | 180 (105-280) | 270 (120-300) | .28 |
Case with CD123+ cells, n (%) | 6 (86) | 9/10 (90)‖ | >.99 |
CD123 expression, median (range) | 50 (0-60) | 15 (0-100) | .32 |
Positive cutaneous DIF, n (%) | 0/3 (0)¶ | 1/2 (50)# | .4 |
Bold values are statistically significant.
CLE, Chilblain lupus erythematosus; DIF, direct immunofluorescence; EC, epidemic chilblains; MxA, myxovirus resistance protein A; SD, standard deviation.
Intensity was scored as follow: 0, absence; 1, rare; 2, moderated; 3, intense.
One CLE biopsy sample did not show the eccrine gland.
Two of CLE biopsy samples did not show the nerve.
Hypodermis was observed in 2 biopsy samples in each groups.
One CLE did not have immunohistochemistry analysis.
Three DIF analyses were performed in the EC group.
Two DIF analyses were performed in the CLE group.